Navigation Links
Monogram Announces 2008 Second Quarter Financial Results
Date:7/29/2008

46) $(15,430)

Basic and diluted net loss per common

share before cumulative effect of

change in accounting principle $(0.04) $(0.03) $(0.05) $(0.13)

Cumulative effect per share of change

in accounting principle $- $- $- $0.01

Basic and diluted net loss per common

share after cumulative effect of

change in accounting principle $(0.04) $(0.03) $(0.05) $(0.12)

Weighted-average shares used in

computing basic net loss per

common share 134,553 132,026 134,372 131,805

Reconciliation of Non-GAAP Proforma

Results to GAAP

Net loss after cumulative effect of

change in accounting principle $(5,518) $(3,872) $(7,246) $(15,430)

Adjustments for certain non-cash

items:

Cumulative effect of change in

accounting principle - - - (2,242)

Contingent Value Rights

valuation adjustment (72) - (72) -

Convertible debt valuation adjustment (66) (4,463) (4,802) (408)

Non-GAAP Proforma net loss (5,656) (8,335) (12,120) (18,080)

Non-GAAP Proforma net loss per common

share, basic $(0.04) $(0.06) $(0.09) $(0.14)

Management believes that this Non-GAAP proforma financial data supplements the Company's GAAP financial statements by providing investors with additional information which allows them to have a clearer picture of the Company's operations, financial performance and the comparability of the Company's operating results from period to period as they exclude the effects of revaluation of the Company's convertible debt that management believes are not indicative of the Company's ongoing operations. The presentation of this additional information is not meant to be considered in isolation or as a substitute
'/>"/>

SOURCE Monogram Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Monogram Announces First Medicare Payment for Trofile(TM)
2. Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference
3. Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay
4. Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies
5. Monogram Announces Commercial Availability of the HERmark(TM) Breast Cancer Assay
6. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
7. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
8. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
9. HEI, Inc. Announces Sale of RFID Division Assets
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2009)... from more emotional and behavioral difficulties when compared to ... the most when a parent is deployed overseas, according ... that having a parent deployed for a longer period ... struggled with emotional problems were important factors associated with ... study published online by the journal Pediatrics . ...
(Date:12/6/2009)... Consumers advised to avoid oysters harvested from San Antonio ... -- The U.S. Food and Drug Administration is advising ... Antonio Bay on or after Nov. 16 due to ... consumed oysters harvested from this area, which is located ... http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) ,, The FDA, along with ...
(Date:12/6/2009)... study by researchers from the Medical College of Wisconsin, ... for pain and other sickle cell disease complications in ... both providers and patients were also identified. The ... professor of pediatrics at the Medical College and Children,s ... be presented at the American Society of Hematology meeting ...
(Date:12/6/2009)... www.sleeping-with-a-sleeping-disorder.com is asking people ,who have ... aids from around the world to donate their ... submissions will be compiled in an ebook titled ... be sold from the website in early January ... proceeds ,from sales of the E-book to three ...
(Date:12/5/2009)... Dec. 5 ,, What: Cuts for ... difference in the fight against cancer and other terminal illnesses ... be donated to St. Jude Children,s Research Hospital. Guests will ... a delectable and savory Vietnamese restaurant in Falls Church for ...
Breaking Medicine News(10 mins):Health News:Military children face more emotional challenges as parental deployments grow longer, study finds 2Health News:Military children face more emotional challenges as parental deployments grow longer, study finds 3Health News:FDA, CDC, and States Investigating Norovirus Illnesses Linked to Oysters 2Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2
... on findings of a recent study researchers say people ... also is infectious diseases // . ,Previous studies ... of tuberculosis on planes. Results suggest sitting within two ... longer than eight hours places passengers at risk of ...
... in the country of Angola, people had been warned not to ... ,The number of people who are affected by the virus ... Health Organization, the two third of those affected by the virus ... in 1967 is said to cause nausea, stomachaches, vomiting and diarrhea. ...
... that causes a number of blood disorders ahs been found ... to a new study. ,Researchers were able to develop ... in most patients with myeloproliferative blood disorders. These disorders are ... hemorrhage or acute myeloid leukemia. ,A gene called JAK2 ...
... the standard test to detect dementia so that it ... early. The test called National Institute //of Ageing's ... list (CWL) needs only ten minutes to administer. ... dementia as these stages often go undetected. They used ...
... new study has found out that depression has to be ... // used to treat the same. The study was conducted ... first glance, results showed both the newer and older classes ... within the first month of being prescribed.The older class of ...
... new study shows how the risk of death and heart ... It was found that doubling the usual dose of an ... ,Angioplasty is a procedure in which a balloon-tipped catheter is ... plaque in the artery and unblock the vessel. A small ...
Other Medicine News:
(Date:12/6/2009)... SEOUL, Korea, Dec. 6 RNL Bio ... company specialized in adult stem cell therapeutics announced ... Multiple Sclerosis improved tremendously after receiving stem cell ... an autoimmune disease that affects the central nervous ... Sclerosis is a disease in which the nerves ...
(Date:12/4/2009)... INDIANAPOLIS, Dec. 4 The U.S. Food ... tablet form as an option for the treatment of ... I disorder in adolescents aged 13-17 years old. ... take into consideration the increased potential for weight gain ...
(Date:12/4/2009)... Ensure Emergency Deliveries are Transported ,, PHILADELPHIA, ... chapter of the American Red Cross are hard at ... that they endure that could potentially put Philadelphia,s blood ... on strike and set up a picket line yesterday ...
Breaking Medicine Technology:Multiple Sclerosis Patient Finds Hope Through Stem Cell Treatment 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2AMA Supports Health System Reform Alternatives Consistent With Principles of Pluralism Freedom of Choice Freedom of Practice and Universal Access fo 49246 1AMA Supports Health System Reform Alternatives Consistent With Principles of Pluralism Freedom of Choice Freedom of Practice and Universal Access fo 49246 2Pharmaceutical Institute Launches New E Course Focused on Health Policy 12677 1Pharmaceutical Institute Launches New E Course Focused on Health Policy 12677 2Pharmaceutical Institute Launches New E Course Focused on Health Policy 12677 3Structures from the human immune systems oldest branch shed light on a range of diseases 49239 1Structures from the human immune systems oldest branch shed light on a range of diseases 49239 2Structures from the human immune systems oldest branch shed light on a range of diseases 49239 3
... Potential Benefit of Unique OROS(R),Formulation, SAN DIEGO, ... abuse,remains an ongoing concern for parents and ... Hyperactivity Disorder,(ADHD). Data presented on Tuesday at ... Association highlighted findings that,long-acting OROS(R) methylphenidate had ...
... 22, 2007,/PRNewswire-FirstCall/ -- Palatin Technologies, Inc. and ... Study 16 and,Study 17 of the Phase ... with erectile dysfunction (ED) were presented,yesterday at ... 2007) held in Anaheim, CA. New positive ...
Other Medicine Technology:New Data Suggests Less Abuse-Related Effects For OROS,Methylphenidate 2New Data Suggests Less Abuse-Related Effects For OROS,Methylphenidate 3New Data Suggests Less Abuse-Related Effects For OROS,Methylphenidate 4New Data Suggests Less Abuse-Related Effects For OROS,Methylphenidate 5Palatin Technologies and King Pharmaceuticals Report Data Showing,Improvements in Sexual Relationship and Self-Esteem in Patients,with Erectile Dysfunction Treated with Bremelanotide 2Palatin Technologies and King Pharmaceuticals Report Data Showing,Improvements in Sexual Relationship and Self-Esteem in Patients,with Erectile Dysfunction Treated with Bremelanotide 3Palatin Technologies and King Pharmaceuticals Report Data Showing,Improvements in Sexual Relationship and Self-Esteem in Patients,with Erectile Dysfunction Treated with Bremelanotide 4Palatin Technologies and King Pharmaceuticals Report Data Showing,Improvements in Sexual Relationship and Self-Esteem in Patients,with Erectile Dysfunction Treated with Bremelanotide 5Palatin Technologies and King Pharmaceuticals Report Data Showing,Improvements in Sexual Relationship and Self-Esteem in Patients,with Erectile Dysfunction Treated with Bremelanotide 6Palatin Technologies and King Pharmaceuticals Report Data Showing,Improvements in Sexual Relationship and Self-Esteem in Patients,with Erectile Dysfunction Treated with Bremelanotide 7
... Ophthalmic Products provide the ... free products for unparalleled ... cleaning of fine microsurgical ... material is highly absorbent, ...
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
... provide a broad selection of ... a wide variety of ophthalmic ... is packaged sterile, complete with ... switch in the "off " ...
Medicine Products: